Press Releases

PLYMOUTH MEETING, Pa., Jan. 27, 2020 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (

Read more...

MELBOURNE, Fla., Jan. 27, 2020 /PRNewswire/ -- The Preeclampsia Foundation announced today that Nicole Purnell, program manager of MoMMA's Voices, has been selected to serve on the National Quality Forum's Maternal Morbidity and Mortality Committee as a patient advocate. While the majority of the committee's members are medical and sci

Read more...

NORTH FALMOUTH, Mass., Jan. 27, 2020 /PRNewswire/ -- The Quell Foundation is proud to announce Chelsea Trotter as its first Director of prestigious scholarship program. In her new role, Ms. Trotter will report directly to Kevin M. Lynch, CEO of The Quell Foundation. "Chelsea is a valuable talent with a passion for our mission

Read more...

SANTA ANA, Calif., Jan. 27, 2020 /PRNewswire/ -- Cognita Labs, a respiratory technologies company, announced U.S. Food and Drug Administration (FDA) clearance for CapMedic, world's first interactive digital inhaler sensor for asthma, Chronic Obstructive Pulmonary Disease (COPD) and other pulmonary conditions.

Read more...

NEW YORK, Jan. 27, 2020 /PRNewswire/ -- The US Navy Veterans Lung Cancer Advocate is urging a US Navy Veteran or person who has been diagnosed with lung cancer to c

Read more...

SAN DIEGO and PENNINGTON, N.J., Jan. 27, 2020 /PRNewswire/ -- OncoSec Medical Incorporated ("OncoSec") (Nasdaq: ONCS), a company developing late-stage intratumoral cancer immunotherapies, today announced data from initial feasibility studies of its novel visceral lesion applicator (VLA) have been accepted to be presented at the Annual Mee

Read more...

PRINCETON, N.J., Jan. 27, 2020 /PRNewswire/ -- Systech, the global technology leader in brand protection and digital product authentica

Read more...

TEL AVIV, Israel and BETHESDA, Maryland, Jan. 27, 2020 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that in a series of tests conducted at the company's Hig

Read more...

NORTH CHICAGO, Ill., Jan. 27, 2020 /PRNewswire/ -- AbbVie Inc. (NYSE:ABBV) ("AbbVie") announced today the extension of the expiration date of the offers to exchange (each, an "Exchange Offer" and, collectively, the "Exchange Offers") any and all outstanding notes of certain series issued by Allergan Finance, LLC ("Allergan Finance"), Allergan, Inc. ("Allergan Inc"),

Read more...

ATLANTA, Jan. 27, 2020 /PRNewswire/ -- Functional solutions that help you achieve antibiotic-free production: that is the promise German-based attendee EW Nutrition makes at this year's IPPE. Recognizing that the challenges of antimicrobial resistance are now spilling from animal production into human welfare, the company is pushing for drastic action to ensure that

Read more...